KR101853993B1 - 펩티드 방사성추적자 조성물 - Google Patents

펩티드 방사성추적자 조성물 Download PDF

Info

Publication number
KR101853993B1
KR101853993B1 KR1020137006689A KR20137006689A KR101853993B1 KR 101853993 B1 KR101853993 B1 KR 101853993B1 KR 1020137006689 A KR1020137006689 A KR 1020137006689A KR 20137006689 A KR20137006689 A KR 20137006689A KR 101853993 B1 KR101853993 B1 KR 101853993B1
Authority
KR
South Korea
Prior art keywords
cys
peptide
gly
cmbp
cyclic peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020137006689A
Other languages
English (en)
Korean (ko)
Other versions
KR20130135242A (ko
Inventor
피터 브라이언 이베슨
라지브 발라
바르트 인드레볼
가레트 겟볼드젠
Original Assignee
지이 헬쓰케어 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 지이 헬쓰케어 리미티드 filed Critical 지이 헬쓰케어 리미티드
Publication of KR20130135242A publication Critical patent/KR20130135242A/ko
Application granted granted Critical
Publication of KR101853993B1 publication Critical patent/KR101853993B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nuclear Medicine (AREA)
KR1020137006689A 2010-08-18 2011-08-11 펩티드 방사성추적자 조성물 Active KR101853993B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1013808.9 2010-08-18
GBGB1013808.9A GB201013808D0 (en) 2010-08-18 2010-08-18 Peptide radiotracer compositions
PCT/EP2011/063890 WO2012022676A1 (en) 2010-08-18 2011-08-11 Peptide radiotracer compositions

Publications (2)

Publication Number Publication Date
KR20130135242A KR20130135242A (ko) 2013-12-10
KR101853993B1 true KR101853993B1 (ko) 2018-05-02

Family

ID=42938098

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020137006689A Active KR101853993B1 (ko) 2010-08-18 2011-08-11 펩티드 방사성추적자 조성물

Country Status (19)

Country Link
US (1) US9533059B2 (enExample)
EP (1) EP2605802B1 (enExample)
JP (1) JP6014592B2 (enExample)
KR (1) KR101853993B1 (enExample)
CN (1) CN103153350B (enExample)
AU (1) AU2011290856B2 (enExample)
BR (1) BR112013003469A2 (enExample)
CA (1) CA2807491C (enExample)
CL (1) CL2013000483A1 (enExample)
ES (1) ES2626410T3 (enExample)
GB (1) GB201013808D0 (enExample)
IL (1) IL224463A (enExample)
MX (1) MX348733B (enExample)
MY (1) MY163136A (enExample)
NZ (1) NZ606466A (enExample)
PH (1) PH12013500270A1 (enExample)
RU (1) RU2594167C2 (enExample)
SG (1) SG187878A1 (enExample)
WO (1) WO2012022676A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102061366B1 (ko) 2011-12-20 2019-12-31 지이 헬쓰케어 리미티드 환자 선정방법

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201103696D0 (en) * 2011-03-04 2011-04-20 Ge Healthcare Ltd Technetium labelled peptides
GB201209082D0 (en) * 2012-05-24 2012-07-04 Ge Healthcare Ltd Purification method
GB201221266D0 (en) * 2012-11-27 2013-01-09 Ge Healthcare Ltd Aldehyde compositions
GB201314936D0 (en) 2013-08-21 2013-10-02 Ge Healthcare Ltd Radiolabelling method
GB201322451D0 (en) * 2013-12-18 2014-02-05 Ge Healthcare Ltd Purification method and compositions
GB201322456D0 (en) * 2013-12-18 2014-02-05 Ge Healthcare Ltd Radiotracer compositions and methods
US20190151483A1 (en) * 2016-07-25 2019-05-23 The United States Of America, As Represented By The Secretary, Department Of Health And Human Serv Methods of making 18f-labeled precursors and peptides, labeled c-met binding peptides, and methods of use thereof
GB201804835D0 (en) * 2018-03-26 2018-05-09 Ge Healthcare As Formulation and method of preparation
CN114222592A (zh) 2019-06-14 2022-03-22 爱丁堡分子成像有限公司 化合物和使用方法
GB201915206D0 (en) * 2019-10-21 2019-12-04 Ge Healthcare Ltd Use of cyclodextrins as a radiostabilizer
SE2050387A1 (en) * 2020-04-06 2021-10-07 Pvac Medical Tech Ltd Labelled substance and methods of detection of inflammation and infection using said substance
TW202509086A (zh) * 2021-03-22 2025-03-01 日商肽夢想股份有限公司 c－Met蛋白質結合肽複合物

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009106566A2 (en) 2008-02-26 2009-09-03 Ge Healthcare As Therapy selection method
JP2009542689A (ja) * 2006-07-07 2009-12-03 ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ 選択的カスパーゼ阻害剤

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5961955A (en) * 1997-06-03 1999-10-05 Coulter Pharmaceutical, Inc. Radioprotectant for peptides labeled with radioisotope
WO2003057155A2 (en) 2001-12-27 2003-07-17 Van Andel Research Institute Monoclonal antibody imaging and therapy of tumors that express met and bind hepatocyte growth factor
ES2396368T3 (es) * 2003-03-03 2013-02-21 Dyax Corporation Péptidos que se unen específicamente al receptor del HGF (CMET) y usos de los mismos
GB0305704D0 (en) * 2003-03-13 2003-04-16 Amersham Plc Radiofluorination methods
GB0420344D0 (en) * 2004-09-14 2004-10-13 Amersham Plc Diagnostic compounds
GB0615211D0 (en) 2006-07-31 2006-09-06 Ge Healthcare Uk Ltd Asymmetric flouro-substituted polymethine dyes
US8557776B2 (en) 2006-09-08 2013-10-15 Bayer Pharma AG Compounds and methods for 18F labeled agents
WO2008072976A2 (en) 2006-12-13 2008-06-19 Ge Healthcare As Synthesis of a radiofluorinated peptide using microwave activation technology
US8216548B2 (en) * 2006-12-28 2012-07-10 Ge Healthcare As Radiofluorination methods
EA200901142A1 (ru) * 2007-03-01 2010-04-30 Байер Шеринг Фарма Акциенгезельшафт 18f фторбензоильные меченые биологически активные соединения в качестве диагностических визуализирующих средств, а также бензотриазол-1-илоксибензоильные, 2,5-(диоксопирролидин-1-илокси)бензоильные и триметиламмониобензоильные предшественники
CN101848734B (zh) 2007-05-16 2013-08-28 通用电气医疗集团股份有限公司 用于成像的经标记的iigf结合肽
GB0718967D0 (en) * 2007-09-28 2007-11-07 Ge Healthcare Ltd Peptide imaging agents
GB0718957D0 (en) 2007-09-28 2007-11-07 Ge Healthcare Ltd Optical imaging agents
GB0716897D0 (en) 2007-08-30 2007-10-10 Univ Muenchen Tech Cancer imaging and treatment

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009542689A (ja) * 2006-07-07 2009-12-03 ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ 選択的カスパーゼ阻害剤
WO2009106566A2 (en) 2008-02-26 2009-09-03 Ge Healthcare As Therapy selection method

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102061366B1 (ko) 2011-12-20 2019-12-31 지이 헬쓰케어 리미티드 환자 선정방법

Also Published As

Publication number Publication date
PH12013500270A1 (en) 2013-04-01
EP2605802B1 (en) 2017-04-26
US9533059B2 (en) 2017-01-03
CA2807491C (en) 2019-06-04
EP2605802A1 (en) 2013-06-26
MX348733B (es) 2017-06-27
KR20130135242A (ko) 2013-12-10
JP2013540702A (ja) 2013-11-07
US20130149241A1 (en) 2013-06-13
MX2013001939A (es) 2013-03-18
CL2013000483A1 (es) 2014-03-07
WO2012022676A1 (en) 2012-02-23
AU2011290856B2 (en) 2014-12-04
CN103153350A (zh) 2013-06-12
IL224463A (en) 2016-05-31
GB201013808D0 (en) 2010-09-29
BR112013003469A2 (pt) 2016-06-21
JP6014592B2 (ja) 2016-10-25
RU2013105491A (ru) 2014-09-27
CA2807491A1 (en) 2012-02-23
NZ606466A (en) 2014-11-28
SG187878A1 (en) 2013-03-28
MY163136A (en) 2017-08-15
CN103153350B (zh) 2016-06-29
ES2626410T3 (es) 2017-07-25
AU2011290856A1 (en) 2013-03-14
RU2594167C2 (ru) 2016-08-10

Similar Documents

Publication Publication Date Title
KR101853993B1 (ko) 펩티드 방사성추적자 조성물
JP2020516676A (ja) 二重標的イメージング用分子プローブ及びその調製方法と応用
US20220202965A1 (en) Radiotracer compositions and methods
JP2014505021A (ja) アポトーシス用ｐｅｔイメージング剤
KR20140012112A (ko) 테크네튬 표지화 펩티드
KR102061366B1 (ko) 환자 선정방법
US20220273830A1 (en) Compounds and methods of use
HK1186119A (en) Peptide radiotracer compositions
WO2025061971A1 (en) Functionalized peptides for in-vivo addressing of pd-l1 expression
HK1186119B (en) Peptide radiotracer compositions

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20130315

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20160719

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20170809

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20171214

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20170809

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

AMND Amendment
PX0901 Re-examination

Patent event code: PX09011S01I

Patent event date: 20171214

Comment text: Decision to Refuse Application

Patent event code: PX09012R01I

Patent event date: 20171027

Comment text: Amendment to Specification, etc.

PX0701 Decision of registration after re-examination

Patent event date: 20180201

Comment text: Decision to Grant Registration

Patent event code: PX07013S01D

Patent event date: 20180115

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

Patent event date: 20171214

Comment text: Decision to Refuse Application

Patent event code: PX07011S01I

Patent event date: 20171027

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

X701 Decision to grant (after re-examination)
GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20180425

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20180425

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20210329

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20220324

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20240401

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 20250324

Start annual number: 8

End annual number: 8